🇺🇸 Scalp blocks with ropivacaine and intravenous parecoxib in United States

Scalp blocks with ropivacaine and intravenous parecoxib (Scalp blocks with ropivacaine and intravenous parecoxib) regulatory status in United States.

Marketing authorisation

FDA

  • Status: approved

Scalp blocks with ropivacaine and intravenous parecoxib in other countries

Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.

Frequently asked questions

Is Scalp blocks with ropivacaine and intravenous parecoxib approved in United States?

Yes. FDA has authorised it.

Who is the marketing authorisation holder for Scalp blocks with ropivacaine and intravenous parecoxib in United States?

Beijing Tiantan Hospital is the originator. The local marketing authorisation holder may differ — check the official source linked above.